The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Total assets of GW Pharmaceuticals from 2017 to 2020 (in million U.S. dollars)
Total assets of GW Pharmaceuticals 2017-2020
In 2020, GW Pharmaceuticals had around 940 million U.S. dollars in total assets, which is a significant improvement from around 443 million U.S. dollars in total assets in 2017. This statistic illustrates the total assets of GW Pharmaceuticals worldwide from 2017 to 2020.
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Net loss of GW Pharmaceuticals from 2017 to 2020
- Basic Statistic Total operating expenses of GW Pharmaceuticals 2017-2020
- Premium Statistic Total revenue of GW Pharmaceuticals 2017-2020
- Basic Statistic Total assets of Jazz Pharmaceuticals 2016-2024
- Basic Statistic Number of employees at GW Pharmaceuticals 2020, by geography
- Premium Statistic Total revenue of Jazz Pharmaceuticals 2016-2024
- Basic Statistic Jazz Pharmaceuticals R&D expenditure 2016-2024
- Basic Statistic Medical cannabis patients Canada 2023-2027
- Premium Statistic Medical cannabis market size in the United States 2023-2027
- Premium Statistic Medical cannabis market size forecast by U.S. state 2027
About the region
10
- Premium Statistic Jazz Pharmaceuticals top products sales 2022-2024
- Basic Statistic Share of cannabis clinical trials worldwide by sponsor 2010-2023
- Premium Statistic Sales forecast of major cannabis pharmaceutical products by world region 2023-2027
- Premium Statistic Countries in Africa with the most cannabis consumers in 2018
- Premium Statistic Sales forecast of major cannabis pharmaceutical products worldwide 2023-2027
- Basic Statistic Popular methods of cannabinoid synthesis worldwide 2021
- Basic Statistic Employees at Jazz Pharmaceuticals 2021-2024, by region
- Basic Statistic Cannabis patents under Jazz Pharmaceuticals by patent family 2023
- Basic Statistic Share of cannabis clinical trials worldwide by intervention 2010-2023
- Premium Statistic Cannabis patents under Jazz Pharmaceuticals' subsidiaries 2023
Selected statistics
10
- Premium Statistic Projected medical cannabis market size in Europe by country 2027
- Basic Statistic Medical cannabis patients Denmark 2023-2027
- Premium Statistic Medical cannabis market value in Italy 2020-2030, by segment
- Premium Statistic Medical cannabis market revenue in the United Kingdom 2023-2027
- Premium Statistic R&D value in the pharma industry in Romania 2013-2022
- Premium Statistic Payment value for pharmaceuticals by health insurance systems in Romania 2013-2022
- Premium Statistic Medical cannabis market revenue in Denmark 2023-2027
- Premium Statistic VAT rates applicable to medicine in Romania 2015-2024
- Premium Statistic VAT rates applicable to medicine in Hungary 2021-2025
- Premium Statistic Sales revenue Kwang Dong Pharmaceutical 2015-2024
Other regions
10
- Premium Statistic Medical cannabis market size in Europe by country 2023
- Premium Statistic Distribution of medical cannabis oil exports Canada 2020, by importer
- Basic Statistic Quarterly medical cannabis oil products sold in Canada 2016-2019
- Premium Statistic Colorado's medical cannabis spending 2018-2024
- Premium Statistic Massachusetts' medical cannabis spending 2018-2024
- Premium Statistic Number of prescriptions for cannabinoid-containing medicines in Germany, 2018 to 2024
- Premium Statistic Medical cannabis market size forecast New Zealand 2023-2027
- Premium Statistic Medical cannabis market size forecast Australia 2023-2027
- Premium Statistic Number of retailers in Colorado and Washington state cannabis markets 2017-2019
- Premium Statistic Monthly sales growth of recreational cannabis in the United States in 2020, by state
Related statistics
10
- Basic Statistic Number of medical cannabis authorizations in Switzerland 2012-2021
- Premium Statistic Largest M&A deals in cannabis industry in North America 2021
- Premium Statistic Employees in the pharma industry in Romania 2013-2022
- Basic Statistic Distribution of medical cannabis patients in select EU countries in 2019, by gender
- Basic Statistic Exports of medical cannabis from Netherlands by country 2022
- Premium Statistic Import value of pharmaceutical products to Romania 2013-2022
- Premium Statistic Number of approved hemp varieties in the EU 2016-2022
- Basic Statistic Exports of medical cannabis from Netherlands 2010-2022
- Basic Statistic Share of THC clinical trials worldwide by condition 2010-2023
- Premium Statistic Main pharmacies in Mexico 2019, by size
Further Content: You might find this interesting as well
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
GW Pharmaceuticals. (February 26, 2021). Total assets of GW Pharmaceuticals from 2017 to 2020 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 27, 2026, from /statistics/1264975/total-assets-of-gw-pharmaceuticals/
GW Pharmaceuticals. "Total assets of GW Pharmaceuticals from 2017 to 2020 (in million U.S. dollars)." Chart. February 26, 2021. ÌÇÐÄÆƽâ°æ. Accessed July 27, 2026. /statistics/1264975/total-assets-of-gw-pharmaceuticals/
GW Pharmaceuticals. (2021). Total assets of GW Pharmaceuticals from 2017 to 2020 (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 27, 2026. /statistics/1264975/total-assets-of-gw-pharmaceuticals/
GW Pharmaceuticals. "Total Assets of Gw Pharmaceuticals from 2017 to 2020 (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 26 Feb 2021, /statistics/1264975/total-assets-of-gw-pharmaceuticals/
GW Pharmaceuticals, Total assets of GW Pharmaceuticals from 2017 to 2020 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/1264975/total-assets-of-gw-pharmaceuticals/ (last visited July 27, 2026)
Total assets of GW Pharmaceuticals from 2017 to 2020 (in million U.S. dollars) [Graph], GW Pharmaceuticals, February 26, 2021. [Online]. Available: /statistics/1264975/total-assets-of-gw-pharmaceuticals/
Advertisement